138 related articles for article (PubMed ID: 24434379)
1. CD20 antigen expression by lymphoma cells in lung allograft recipients is associated with higher remission rate and superior survival: a study on heart and lung transplant recipients.
Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):29-37. PubMed ID: 24434379
[TBL] [Abstract][Full Text] [Related]
2. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.
Ramalingam P; Rybicki L; Smith MD; Abrahams NA; Tubbs RR; Pettay J; Farver CF; Hsi ED
Mod Pathol; 2002 Jun; 15(6):647-56. PubMed ID: 12065779
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
7. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
Lim GY; Newman B; Kurland G; Webber SA
Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
[TBL] [Abstract][Full Text] [Related]
9. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ
J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197
[TBL] [Abstract][Full Text] [Related]
11. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
12. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
Izadi M; Taheri S
Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
[TBL] [Abstract][Full Text] [Related]
13. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
14. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
Kremer BE; Reshef R; Misleh JG; Christie JD; Ahya VN; Blumenthal NP; Kotloff RM; Hadjiliadis D; Stadtmauer EA; Schuster SJ; Tsai DE
J Heart Lung Transplant; 2012 Mar; 31(3):296-304. PubMed ID: 22112992
[TBL] [Abstract][Full Text] [Related]
16. Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey.
Izadi M; Taheri S
Prog Transplant; 2011 Dec; 21(4):353-9. PubMed ID: 22549000
[TBL] [Abstract][Full Text] [Related]
17. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
Gao SZ; Chaparro SV; Perlroth M; Montoya JG; Miller JL; DiMiceli S; Hastie T; Oyer PE; Schroeder J
J Heart Lung Transplant; 2003 May; 22(5):505-14. PubMed ID: 12742411
[TBL] [Abstract][Full Text] [Related]
18. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
Lowery EM; Adams W; Grim SA; Clark NM; Edwards L; Layden JE
J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
[TBL] [Abstract][Full Text] [Related]
20. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
